These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 34918264)

  • 1. The Regulatory Evaluation of Vaccines for Human Use.
    Baylor NW
    Methods Mol Biol; 2022; 2412():483-501. PubMed ID: 34918264
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Regulatory Evaluation of Vaccines for Human Use.
    Baylor NW
    Methods Mol Biol; 2016; 1404():773-787. PubMed ID: 27076337
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adjuvants and delivery issues related to immunization: a survey of the recent patent literature.
    Mrsny RJ
    J Drug Target; 1998; 6(4):243-9. PubMed ID: 9894692
    [TBL] [Abstract][Full Text] [Related]  

  • 4. History of regulatory requirements for poultry biologics in the United States, 1970s to 1990s.
    Espeseth DA; Lasher H
    Avian Dis; 2013 Jun; 57(2):167-71. PubMed ID: 24689169
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influenza virus vaccine live intranasal--MedImmune vaccines: CAIV-T, influenza vaccine live intranasal.
    Drugs R D; 2003; 4(5):312-9. PubMed ID: 12952502
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Food and Drug Administration regulation and evaluation of vaccines.
    Marshall V; Baylor NW
    Pediatrics; 2011 May; 127 Suppl 1():S23-30. PubMed ID: 21502242
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Licensing procedures for human vaccines in Germany and Europe and the WHO prequalification program].
    Grabski E; Hildt E; Wagner R
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2020 Jan; 63(1):4-15. PubMed ID: 31776598
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulatory issues relating to the use of recombinant vectors in production of human vaccines.
    Marcus-Sekura CJ
    Dev Biol Stand; 1994; 82():107-12. PubMed ID: 7958464
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A view on regulatory aspects of live viral vaccine safety.
    Horaud F
    Dev Biol Stand; 1994; 82():113-8. PubMed ID: 7958465
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Rapid Development and Early Success of Covid 19 Vaccines Have Raised Hopes for Accelerating the Cancer Treatment Mechanism.
    Amanpour S
    Arch Razi Inst; 2021 Mar; 76(1):1-6. PubMed ID: 33818952
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Manufacturing issues with combining different antigens: a regulatory perspective.
    Falk LA; Arciniega J; McVittie L
    Clin Infect Dis; 2001 Dec; 33 Suppl 4():S351-5. PubMed ID: 11709772
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Host cell protein testing strategy for hepatitis B antigen in Hexavalent vaccine - Towards a general testing strategy for recombinant vaccines.
    Toinon A; Fontaine C; Thion L; Gajewska B; Carpick B; Nougarede N; Uhlrich S
    Biologicals; 2018 Jul; 54():1-7. PubMed ID: 29861269
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fish vaccine antigens produced or delivered by recombinant DNA technologies.
    Leong JC; Anderson E; Bootland LM; Chiou PW; Johnson M; Kim C; Mourich D; Trobridge G
    Dev Biol Stand; 1997; 90():267-77. PubMed ID: 9270855
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Authorities and procedures for licensing veterinary biological products in the United States.
    Espeseth DA; Myers TJ
    Adv Vet Med; 1999; 41():585-93. PubMed ID: 9890045
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Live oral Salmonella vaccines: potential use of attenuated strains as carriers of heterologous antigens to the immune system.
    Dougan G; Hormaeche CE; Maskell DJ
    Parasite Immunol; 1987 Mar; 9(2):151-60. PubMed ID: 3106921
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quality assessment of DNA vaccines: hepatitis-B vaccine.
    Peetermans JH
    J Pharm Biomed Anal; 1989; 7(2):227-32. PubMed ID: 2535120
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetically engineered vaccines: an overview.
    Dertzbaugh MT
    Plasmid; 1998; 39(2):100-13. PubMed ID: 9514708
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Japanese encephalitis vaccines: current vaccines and future prospects.
    Monath TP
    Curr Top Microbiol Immunol; 2002; 267():105-38. PubMed ID: 12082985
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vibrio cholerae vaccines.
    Kaper JB
    Rev Infect Dis; 1989; 11 Suppl 3():S568-73. PubMed ID: 2669100
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Canadian regulatory requirements for recombinant fish vaccines.
    Sethi MS; Gifford GA; Samagh BS
    Dev Biol Stand; 1997; 90():347-53. PubMed ID: 9270863
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.